Interpretable machine learning for predicting immunotherapy response in gastric cancer via serum cytokine profiling and organoid co-culture platforms
Open Access
- 19 August 2026
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 75 (11)
Abstract
Background Immunotherapy has become a promising strategy for gastric cancer, yet predicting treatment response remains challenging. We developed an exploratory, biologically informed machine learning framework integrating peri-treatment serum biomarkers and clinical variables, with candidate cytokines informed by an in vitro patient-derived organoids (PDOs)–cancer-associated fibroblasts (CAFs)–T cells co-culture platform, to assess pathological response to PD-1 inhibitor (PD-1i)-based therapy in gastric cancer. Methods Data from 125 patients receiving PD-1i were analyzed. Serum samples collected before and after immunotherapy were tested for cytokines. Eighteen successfully established PDOs-CAFs-T cells co-culture models were used for cytokine profiling and to identify seven candidate cytokines. These cytokines were subsequently measured in paired serum samples from the 125-patient clinical cohort and combined with clinicopathological variables for machine learning model development. Tumor Regression Grade (TRG) served as the binary outcome variable, representing patients with good versus poor/no tumor regression. Experimental and clinical data were used to train predictive models with multiple algorithms, including CatBoost and several other machine learning methods. Model performance was assessed by tenfold cross-validation, ROC, precision-recall (PR) Curve, and decision curve analyses. Feature importance was interpreted using Shapley additive explanations (SHAP) and visualized using decision tree. Results The PDOs-CAFs-T cells co-culture platform showed cytokine-change trends that were generally concordant with those observed in patient serum after treatment. 10 key predictors were identified, including pre-/post-treatment maximum diameter, ycT/ycN stages, and pre- or post-treatment cytokines (IFN-α2, IL-2, IL-6, IL-8, MCP-1). In the internal testing set, the tuned CatBoost model achieved an AUC of 0.845. SHAP analysis revealed post-treatment maximum diameter and cytokine profiles as the most influential features. Decision trees clearly and interpretably present the model. Conclusion This study presents an exploratory, biologically informed machine learning framework for peri-treatment assessment of pathological response in gastric cancer. The PDOs-CAFs-T cells co-culture platform provided biological context for candidate cytokine selection.Keywords
Funding Information
- The National Natural Science Foundation of China (No. 82403423)
- The National Natural Science Foundation of China (No. 82102785)
- Wujieping Medical Foundation (No.320.6750.2023-07-4)
- Wujieping Medical Foundation (No.320.6750.2024-17-26)
- Yantai Science and Technology Project (2025YD093)
- Shandong Province Medical and Health Technology Project (202304010040)
- Taishan Scholar Project (No.ts20190991)
- the Key R&D project of Shandong Province (2022CXPT023)
- the Natural Science Foundation of Shandong province (ZR2021QH314)
This publication has 55 references indexed in Scilit:
- A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic ScreeningCell Stem Cell, 2018
- Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor OrganoidsCell, 2018
- Patient-derived organoids model treatment response of metastatic gastrointestinal cancersScience, 2018
- Microfluidic Organ-on-a-Chip Models of Human IntestineCellular and Molecular Gastroenterology and Hepatology, 2018
- Tumor regression grading of gastrointestinal cancers after neoadjuvant therapyVirchows Archiv, 2017
- Machine Learning in MedicineCirculation, 2015
- Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid TumorsPLOS ONE, 2015
- Long-term Survival Outcomes of Advanced Gastric Cancer Patients Who Achieved a Pathological Complete Response with Neoadjuvant Chemotherapy: A Systematic Review of the LiteratureAnnals of Surgical Oncology, 2014
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 EfficacyScience Translational Medicine, 2014
- The role of interleukin-2 during homeostasis and activation of the immune systemNature Reviews Immunology, 2012